Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis (Q31141947)

29 June 2017

0 references

Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis (English)

1 reference

29 June 2017

1 reference

1 reference

Jack V Tu

7

0 references

author name string

Douglas S Lee

1

1 reference

29 June 2017

Lawrence D Green

2

1 reference

29 June 2017

Peter P Liu

3

1 reference

29 June 2017

Paul Dorian

4

1 reference

29 June 2017

David M Newman

5

1 reference

29 June 2017

F Curry Grant

6

1 reference

29 June 2017

David A Alter

8

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American College of Cardiology

29 June 2017

1 reference

29 June 2017

41

1 reference

29 June 2017

9

1 reference

29 June 2017

1573-1582

1 reference

Management of ventricular arrhythmias: detection, drugs, and devices.

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: an antagonist's viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Adverse effects of low dose amiodarone: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Survival after implantation of the cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

1 reference

7 January 2021

Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Predictive power of increased QT dispersion in ventricular extrasystoles and in sinus beats for risk stratification after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Cost-effectiveness of the implantable cardioverter defibrillator?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

Estimating treatment benefits for the elderly: the effect of competing risks

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900253-5

7 January 2021

10.1016/S0735-1097(03)00253-5

Identifiers

DOI

1 reference

29 June 2017

1 reference